Colin Blakemore

Character introduction

Positions
2019  Yeung Kin Man Chair Professor of Neuroscience, City University of Hong Kong
2019  Distinguished Guest Professor, Chinese Academy of Sciences Institute of Neuroscience, Shanghai; and International Center for Primate Brain Research, Shanghai
2017  Senior Fellow, Hong Kong Institute for Advanced Study, City University of Hong Kong
2019  Honorary Professorial Fellow, Institute of Philosophy, School of Advanced Study, University of London
2012  Emeritus Professor of Neuroscience, University of Oxford
2012  Emeritus Fellow of Magdalen College, Oxford
2008  Adjunct Professor, Duke-NUS Graduate Medical School, Singapore  
2010  Honorary Professor, Medical School, University of Warwick

Research and achievements
Sir Colin Blakemore is Yeung Kin Man Professor of Neuroscience at City University of Hong Kong, Emeritus Professor of Neuroscience at Oxford and Honorary Professorial Fellow at the School of Advanced Study, London. He worked in the medical schools of Cambridge and Oxford for more than 40 years and from 2003-7 he was Chief Executive of the UK Medical Research Council. His research has focused on vision, development and plasticity of the brain, and neurodegenerative disease. Colin has been President of the British Science Association, the British Neuroscience Association, the Physiological Society and the Royal Society of Biology. He is a member of 12 scientific academies, including the Royal Society and the Chinese Academy of Engineering, and his honours include both the Faraday Prize and the Ferrier Prize from the Royal Society and the Friendship Award from the Chinese government. He has been involved in scientific advice to government and in public communication about science. He first visited China as a guest of the government in 1974 and has had many links with China since then.

Topic: One Health. A Challenge for the Future of Medical Science

Abstract  Modern medicine is founded on many supporting disciplines, including biomedical sciences, genetics and genomics, epidemiology and social sciences. But the new concept of One Health, embracing the complexity of food chains and ecosystems as well as veterinary and human medicine, demands a commitment to interdisciplinary research unprecedented in scale. I shall explore a number of examples - the emergence of the Nipah virus, transmission of rabies, the response to ‘Mad Cow Disease’ in the UK, and the aetiology of amblyopia ex anopsia (‘lazy eye’). Neuroscience, developmental biology, molecular genetics, anthropology, public engagement, psychology, food science and food policy all played a part in the gradual understanding of these disorders and the design of strategies for treatment or prevention. Research in One Health will flourish in universities and institutes that encourage interdisciplinarity, and will require funding agencies, publishers and the peer-review system to recognise the particular needs of interdisciplinary research.


Previous     Lonnie G. Thompson

Next     last_page

<../html>